The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 2014 ACR/ARHP Annual Meeting: Autoimmune Connective Tissue Diseases and Cancer

2014 ACR/ARHP Annual Meeting: Autoimmune Connective Tissue Diseases and Cancer

April 1, 2015 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • 2014 ACR/ARHP Annual Meeting: Super Proteins Eyed in Therapies for Rheumatic Diseases
  • 2014 ACR/ARHP Annual Meeting: Sjögren’s Complications
  • 2015 ACR/ARHP Annual Meeting: Role of Tumor Necrosis Factor Cytokines in Autoimmune Diseases Examined
Explore This Issue
April 2015
Also By This Author
  • 2015 ACR/ARHP Annual Meeting: Metabolic Pathways Linked with Inflammatory Diseases
Mopic/shutterstock.com
Image Credit: docstockmedia/shutterstock.com
In rheumatic disease patients, cancer and autoimmunity sometimes come together.

BOSTON—Associations between rheumatic diseases and cancer have been noted clinically for many decades, but only recently have some of the risk factors and possible mechanisms become clear. Rheumatologists should be aware of which connective tissue disease patients may be at increased malignancy risk and when it’s time to screen for cancer.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Shah
Dr. Shah

“It is our responsibility as rheumatologists to include cancer screening as part of our practice,” said Ami Shah, MD, MHS, assistant professor of medicine at Johns Hopkins Scleroderma Center in Baltimore. Dr. Shah and two other experts spoke on the latest research on the connections between autoimmunity and cancer, and what steps rheumatologists may take to diagnose malignancies quickly and refer those patients for therapy, at the ACR/ARHP Annual Meeting in Boston on Nov. 16, 2014. At the session, Current Understanding of Malignancies in Connective Tissue Diseases, they discussed risk factors that may prompt cancer screening.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Cancer–Myositis Connection

Although over the last century many anecdotal reports pointed to a connection between cancer and myositis, the association between the two diseases has long been questioned by scientists due to referral biases, small studies without appropriate control groups or unclear diagnostic criteria, said Frederick W. Miller, MD, PhD, chief of the Environmental Autoimmunity Group at the National Institute of Environmental Health Sciences in Bethesda, Md. Only in the past several decades have data drawn from Swedish and Australian registries confirmed increased rates of cancers in myositis patients, especially ovarian, breast and pancreatic malignancies. Most patients developed cancer within two to three years of their myositis diagnoses, and dermatomyositis patients had the highest risk, Dr. Miller said.

“Many studies have also suggested that cancer is the leading cause of death when it occurs with either polymyositis or dermatomyositis, and thus, the focus should really be on treating the cancer in these patients,” said Dr. Miller. Rheumatologists should look for important risk factors to identify candidates for more careful cancer screening, he said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE
Dr. Miller
Dr. Miller

Patients who are 45 years or older and male; have rapid unexplained weight loss after a myositis diagnosis; present with cutaneous necrosis, vasculitis or dysphagia; have high erythrocyte sedimentation rates (ESR) or high C-reactive protein levels; or are found to have autoantibodies to p155 may be at higher risk of malignancy, Dr. Miller noted. In addition, autoantibodies to nuclear matrix protein (NXP-2) or transcriptional intermediary factor (TIF1ɣ) may also be associated with cancer in myositis patients.

Pages: 1 2 3 4 | Single Page

Filed Under: Meeting Reports Tagged With: ACR/ARHP Annual Meeting, Autoimmune, Bernstein, Cancer, connective tissue disease, malignancy, patient care, rheumatology, screeningIssue: April 2015

You Might Also Like:
  • 2014 ACR/ARHP Annual Meeting: Super Proteins Eyed in Therapies for Rheumatic Diseases
  • 2014 ACR/ARHP Annual Meeting: Sjögren’s Complications
  • 2015 ACR/ARHP Annual Meeting: Role of Tumor Necrosis Factor Cytokines in Autoimmune Diseases Examined
  • 2015 ACR/ARHP Annual Meeting: T Follicular Helper Cells Emerge as Potential Treatment Target for Autoimmune Diseases

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)